Japan Blood Products Organization   Report issue

For profit Phase 3
Founded: Tokyo Japan (2012)
Status: No NME R&D (2012)

Organization Overview

First Clinical Trial
2012
NCT00335985
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Japan Blood Products Organization